Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

407 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Can intensity-modulated radiotherapy preserve oral health-related quality of life of nasopharyngeal carcinoma patients?
Pow EH, Kwong DL, Sham JS, Lee VH, Ng SC. Pow EH, et al. Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):e213-21. doi: 10.1016/j.ijrobp.2011.12.040. Epub 2012 Mar 2. Int J Radiat Oncol Biol Phys. 2012. PMID: 22386514
Whole-field simultaneous integrated-boost intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma.
Wong FC, Ng AW, Lee VH, Lui CM, Yuen KK, Sze WK, Leung TW, Tung SY. Wong FC, et al. Int J Radiat Oncol Biol Phys. 2010 Jan 1;76(1):138-45. doi: 10.1016/j.ijrobp.2009.01.084. Int J Radiat Oncol Biol Phys. 2010. PMID: 19646824
Comparative analysis of dosimetric parameters of three different radiation techniques for patients with Graves' ophthalmopathy treated with retro-orbital irradiation.
Lee VH, Ng SC, Choi CW, Luk MY, Leung TW, Au GK, Kwong DL. Lee VH, et al. Radiat Oncol. 2012 Nov 26;7:199. doi: 10.1186/1748-717X-7-199. Radiat Oncol. 2012. PMID: 23181900 Free PMC article.
Novel therapy for nasopharyngeal carcinoma--where are we.
Tsang J, Lee VH, Kwong DL. Tsang J, et al. Oral Oncol. 2014 Sep;50(9):798-801. doi: 10.1016/j.oraloncology.2014.01.002. Epub 2014 Jan 22. Oral Oncol. 2014. PMID: 24462373 Review.
Antifungal susceptibility and phenotypic characterization of oral isolates of a black fungus from a nasopharyngeal carcinoma patient under radiotherapy.
Seneviratne CJ, Fong PH, Wong SS, Lee VH. Seneviratne CJ, et al. BMC Oral Health. 2015 Mar 20;15:39. doi: 10.1186/s12903-015-0023-9. BMC Oral Health. 2015. PMID: 25887752 Free PMC article.
Clinical utility of plasma Epstein-Barr virus DNA and ERCC1 single nucleotide polymorphism in nasopharyngeal carcinoma.
Hui EP, Ma BB, Chan KC, Chan CM, Wong CS, To KF, Chan AW, Tung SY, Ng WT, Cheng AC, Lee VH, Chan SL, Loong HH, Kam MK, Leung SF, Ho R, Mo F, Ngan RK, Chan AT. Hui EP, et al. Cancer. 2015 Aug 15;121(16):2720-9. doi: 10.1002/cncr.29413. Epub 2015 May 6. Cancer. 2015. PMID: 25946469
Post-radiation Plasma Epstein-Barr Virus DNA and Local Clinical Remission After Radical Intensity-modulated Radiation Therapy for Nasopharyngeal Carcinoma.
Lee VH, Kwong DL, Leung TW, Choi CW, Lam KO, Sze CK, Ho P, Chan WL, Wong LS, Leung D. Lee VH, et al. Clin Oncol (R Coll Radiol). 2016 Jan;28(1):42-9. doi: 10.1016/j.clon.2015.09.009. Epub 2015 Oct 21. Clin Oncol (R Coll Radiol). 2016. PMID: 26482452
Correlation of PD-L1 Expression of Tumor Cells with Survival Outcomes after Radical Intensity-Modulated Radiation Therapy for Non-Metastatic Nasopharyngeal Carcinoma.
Lee VH, Lo AW, Leung CY, Shek WH, Kwong DL, Lam KO, Tong CC, Sze CK, Leung TW. Lee VH, et al. PLoS One. 2016 Jun 24;11(6):e0157969. doi: 10.1371/journal.pone.0157969. eCollection 2016. PLoS One. 2016. PMID: 27341634 Free PMC article.
Hyperfractionation compared to standard fractionation in intensity-modulated radiation therapy for patients with locally advanced recurrent nasopharyngeal carcinoma.
Lee VH, Kwong DL, Leung TW, Ng SC, Lam KO, Tong CC, Sze CK. Lee VH, et al. Eur Arch Otorhinolaryngol. 2017 Feb;274(2):1067-1078. doi: 10.1007/s00405-016-4339-0. Epub 2016 Oct 13. Eur Arch Otorhinolaryngol. 2017. PMID: 27738820 Clinical Trial.
407 results
Jump to page
Feedback